C. Fonctions-de and C. Grande-similarité-avec, 72 a)72 b), p.72

B. 1. Vigorita, V. Ghelman, B. Mintz, and D. , Orthopaedic Pathology, 2007.

J. Thomas, S. Ayad, and M. Grant, Cartilage collagens: strategies for the study of their organisation and expression in the extracellular matrix., Annals of the Rheumatic Diseases, vol.53, issue.8, p.488, 1994.
DOI : 10.1136/ard.53.8.488

X. Chevalier, Les mécanismes du vieillissement normal et pathologique de l'articulation. Revue du Rhumatisme, pp.455-461, 2004.
DOI : 10.1016/j.rhum.2003.07.011

R. Goggs, S. Carter, G. Schulze-tanzil, M. Shakibaei, and A. Mobasheri, Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis* 1. The Veterinary Journal, pp.140-158, 2003.

L. Laadhar, M. Zitouni, M. Kalle-sellami, M. Mahjoub, S. Sellami et al., Physiopathology of osteoarthritis. From normal cartilage to osteoarthritic cartilage: risk factors and inflammatory mechanisms]. La Revue de médecine interne/fondée... par la Société nationale francaise de médecine interne, p.531, 2007.

H. Hotta, H. Yamada, H. Takaishi, T. Abe, H. Morioka et al., Type II collagen synthesis in the articular cartilage of a rabbit model of osteoarthritis: expression of type II collagen C-propeptide and mRNA especially during early-stage osteoarthritis, Journal of Orthopaedic Science, vol.10, issue.6, pp.595-607, 2005.
DOI : 10.1007/s00776-005-0947-z

C. Fletcher, K. Unni, and F. Mertens, Pathology and genetics of tumours of soft tissue and bone. World Health Organization, 2002.

S. Bernard, M. Murphey, D. Flemming, and M. Kransdorf, Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging. Radiology 10. gouin F, venet guillaume, moreau anne. chondromes, 10p. 11. Lichtenstein L, Jaffe HL. Chondrosarcoma of bone, pp.857-865553, 1943.

M. Murphey, D. Flemming, S. Boyea, J. Bojescul, D. Sweet et al., Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features., RadioGraphics, vol.18, issue.5, pp.1213-1237, 1998.
DOI : 10.1148/radiographics.18.5.9747616

P. Anract, G. De-pinieux, B. Tomeno, D. Eefting, Y. Schrage et al., Chondrosarcomes intraosseux Appareil locomoteur Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors, Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS Am. J. Surg. Pathol. Cancer, vol.14335, issue.13, pp.716-1550, 1952.

H. Evans, A. Ayala, and M. Romsdahl, Prognostic factors in chondrosarcoma of bone

S. Naumann, P. Krallman, K. Unni, M. Fidler, J. Neff et al., A clinicopathologic analysis with emphasis on histologic grading Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma, Cancer, vol.40, issue.18, pp.818-831, 1977.

Y. Park, H. Park, S. Chi, C. Kim, K. Sohn et al., Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma., Oncology Reports, vol.7, issue.5, pp.1041-1047, 2000.
DOI : 10.3892/or.7.5.1041

S. Müller, S. Söder, A. Oliveira, C. Inwards, and T. Aigner, Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton, Modern Pathology, vol.114, issue.8, pp.1088-1094, 2005.
DOI : 10.1083/jcb.114.6.1307

Y. Park, H. Park, S. Chi, S. Ushigome, and K. Unni, Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma, International Journal of Oncology, vol.19, issue.2, pp.353-357, 2001.
DOI : 10.3892/ijo.19.2.353

J. Bovée, A. Cleton-jansen, C. Rosenberg, A. Taminiau, C. Cornelisse et al., Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis, The Journal of Pathology, vol.68, issue.4, pp.454-462, 1999.
DOI : 10.1038/bjc.1993.493

E. Ahlmann, L. Menendez, A. Fedenko, T. Learch, M. De-valk et al., Influence of cryosurgery on treatment outcome of low-grade chondrosarcoma Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1 No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas, Clin. Orthop. Relat. Res. J Surg Oncol Souna BS Clin. Orthop. Relat, vol.45198, issue.25, pp.201-207421, 2006.

. Res, 2010 juill, pp.1956-1962

H. Gelderblom, P. Hogendoorn, S. Dijkstra, C. Van-rijswijk, A. Krol et al., The Clinical Approach Towards Chondrosarcoma, The Oncologist, vol.13, issue.3, pp.320-329, 2008.
DOI : 10.1634/theoncologist.2007-0237

J. Wyman, A. Hornstein, P. Meitner, S. Mak, P. Verdier et al., Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: Expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance PTHR1 mutations associated with Ollier disease result in receptor loss of function, Journal of Orthopaedic Research. Human molecular genetics, vol.171724, issue.6186, pp.935-9402766, 1999.

J. Bovée, A. Cleton-jansen, A. Taminiau, and P. Hogendoorn, Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. The Lancet Oncology, pp.599-607, 2005.

J. Bovée, P. Hogendoorn, J. Wunder, A. Ba-rozeman, L. Hameetman et al., Cartilage tumours and bone development: molecular pathology and possible therapeutic targets Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas, Nat. Rev. Cancer. J. Pathol, vol.10205, issue.324, pp.481-488476, 2005.

Y. Schrage, L. Hameetman, K. Szuhai, A. Cleton-jansen, A. Taminiau et al., Aberrant Heparan Sulfate Proteoglycan Localization, Despite Normal Exostosin, in Central Chondrosarcoma, ):979. 34. van Beerendonk HM, 2009.
DOI : 10.2353/ajpath.2009.080623

A. Jansen, Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression, J. Pathol, vol.202, issue.3, pp.359-366, 2004.

Y. Schrage, I. Machado, D. Meijer, I. Briaire-de-bruijn, B. Van-den-akker et al., COX-2 expression in chondrosarcoma: A role for celecoxib treatment?, European Journal of Cancer, vol.46, issue.3, pp.616-624, 2010.
DOI : 10.1016/j.ejca.2009.11.002

R. Terek, Recent Advances in the Basic Science of Chondrosarcoma, Orthopedic Clinics of North America, vol.37, issue.1, pp.9-14, 2006.
DOI : 10.1016/j.ocl.2005.09.001

J. Bovée, L. Van-den-broek, A. Cleton-jansen, P. Hogendoorn, J. Mirra et al., Upregulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group. Reliability of Histopathologic and Radiologic Grading of Cartilaginous Neoplasms in Long Bones A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones: a clinicopathologic analysis of 51 cases. Clinical orthopaedics and related research, 214. 42. de Pinieux G. chondrosarcome osseux de grade 1: critères diagnostiques. bulletin n°52 de la division française de l'académie internationale de pathologie, pp.1925-1933, 1985.

S. Han, E. Makareeva, N. Kuznetsova, A. Deridder, M. Sutter et al., Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases, Journal of Biological Chemistry, vol.106, issue.29
DOI : 10.1016/j.semcdb.2007.06.008

S. Han, D. Mcbride, W. Losert, S. Leikin, C. Miles et al., Segregation of type I collagen homo-and heterotrimers in fibrils The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues, J. Mol. Biol. J. Mol. Biol, vol.383321, issue.475, pp.122-132797, 2002.

E. Makareeva, S. Han, J. Vera, D. Sackett, K. Holmbeck et al., Carcinomas Contain a Matrix Metalloproteinase-Resistant Isoform of Type I Collagen Exerting Selective Support to Invasion, Molecular Characterisation of Integrin?Procollagen C-Propeptide Interactions, pp.4366-4374274, 1997.
DOI : 10.1158/0008-5472.CAN-09-4057

D. Palmieri, L. Camardella, V. Ulivi, G. Guasco, and P. Manduca, Trimer Carboxyl Propeptide of Collagen I Produced by Mature Osteoblasts Is Chemotactic for Endothelial Cells, Journal of Biological Chemistry, vol.268, issue.1, pp.32658-32663, 2000.
DOI : 10.1002/(SICI)1097-0215(19990505)81:3<395::AID-IJC13>3.0.CO;2-V

D. Palmieri, S. Poggi, V. Ulivi, G. Casartelli, and P. Manduca, Pro-collagen I COOH-terminal Trimer Induces Directional Migration and Metalloproteinases in Breast Cancer Cells, Journal of Biological Chemistry, vol.60, issue.6
DOI : 10.1016/S0092-8674(00)81392-6

J. Burger and T. Kipps, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, vol.107, issue.5, pp.1761-1767
DOI : 10.1182/blood-2005-08-3182

A. Poole, I. Pidoux, A. Reiner, H. Choi, and L. Rosenberg, Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation, The Journal of Cell Biology, vol.98, issue.1
DOI : 10.1083/jcb.98.1.54

E. Lee, Y. Matsui, A. Poole, J. Wu, and D. Eyre, Immunochemical and immunocytochemical studies of the C-propeptide of type II procollagen in chondrocytes of the growth plate The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue, Journal of Histochemistry and Cytochemistry, vol.38, issue.5, 1990.

J. Vincourt, F. Lionneton, G. Kratassiouk, F. Guillemin, P. Netter et al., Establishment of a reliable method for direct proteome characterization of human articular cartilage C- Propeptides of Procollagens I$\alpha$1 and II that Differentially Accumulate in Enchondromas versus Chondrosarcomas Regulate Tumor Cell Survival and Migration, Molecular & Cellular Proteomics. Cancer Research, vol.570, issue.5811, pp.4739-59, 1984.

H. Mankin, K. Cantley, A. Schiller, and L. Lippiello, MMP-13) Expression in Chondrosarcoma Cells and Its Regulation by Basic Fibroblast Growth Factor The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors, Am J Pathol. The Journal of Bone and Joint Surgery, vol.15362, issue.602, pp.91-101176, 1980.

T. Aigner, Towards a new understanding and classification of chondrogenic neoplasias of the skeleton ??? biochemistry and cell biology of chondrosarcoma and its variants, Virchows Archiv, vol.441, issue.3, pp.219-230, 2002.
DOI : 10.1007/s00428-002-0641-x

T. Aigner, S. Dertinger, D. Neureiter, and T. Kirchner, De-differentiated chondrosarcoma is not a ???de-differentiated??? chondrosarcoma, Histopathology, vol.53, issue.1, pp.11-19, 1998.
DOI : 10.1016/0012-1606(76)90220-7

T. Aigner, S. M\üller, D. Neureiter, D. Illstrup, T. Kirchner et al., Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas, Cancer, vol.15, issue.5, pp.2273-2281, 2002.
DOI : 10.1016/S0945-053X(96)90114-6

K. Dornauer, S. Söder, C. Inwards, J. Bovee, and T. Aigner, Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas, Pathology International, vol.273, issue.5, pp.365-372, 2010.
DOI : 10.1016/S0002-9440(10)65003-1

T. Kalinski, S. Krueger, S. Sel, K. Werner, M. Ropke et al., Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin- 1beta. Cancer, pp.2028-2038, 2006.

T. Kalinski, S. Sel, I. Kouznetsova, M. Röpke, and A. Roessner, Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors, Pathology - Research and Practice, vol.205, issue.5, pp.339-345, 2009.
DOI : 10.1016/j.prp.2008.12.008

S. Kauppila, F. Stenb\äck, J. Risteli, A. Jukkola, L. Risteli et al., Aberrant type I and type III collagen gene expression in human breast cancer in vivo Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP, The Journal of Pathology. Cancer research, vol.18657, issue.70, pp.262-2685517, 1997.

T. Aigner, Towards a new understanding and classification of chondrogenic neoplasias of the skeleton ??? biochemistry and cell biology of chondrosarcoma and its variants, Virchows Archiv, vol.441, issue.3, pp.219-249, 2002.
DOI : 10.1007/s00428-002-0641-x

J. Bovee, A. Cleton-jansen, A. Taminiau, and P. Hogendoorn, Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment, The Lancet Oncology, vol.6, issue.8, pp.599-607, 2005.
DOI : 10.1016/S1470-2045(05)70282-5

T. Aigner, S. Muller, D. Neureiter, D. Illstrup, T. Kirchner et al., Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas, Cancer, vol.15, issue.5, pp.2273-81, 2002.
DOI : 10.1016/S0945-053X(96)90114-6

L. Rozeman, P. Hogendoorn, and J. Bovee, Diagnosis and prognosis of chondrosarcoma of bone, Expert Review of Molecular Diagnostics, vol.21, issue.5, pp.461-72, 2002.
DOI : 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G

J. Vincourt, F. Lionneton, and G. Kratassiouk, Establishment of a Reliable Method for Direct Proteome Characterization of Human Articular Cartilage, Molecular & Cellular Proteomics, vol.2, issue.10, pp.1984-95, 2006.
DOI : 10.1074/mcp.M300026-MCP200

URL : https://hal.archives-ouvertes.fr/hal-00103385

F. Ruggiero and M. Koch, Making recombinant extracellular matrix proteins, Methods, vol.45, issue.1, pp.75-85, 2008.
DOI : 10.1016/j.ymeth.2008.01.003

URL : https://hal.archives-ouvertes.fr/hal-00315230

J. Vincourt, J. Vignaud, and F. Lionneton, Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling, Arthritis & Rheumatism, vol.413, issue.9, pp.2798-808, 2008.
DOI : 10.1111/j.1440-169X.2007.00945.x

D. Davies, D. Tuckwell, D. Calderwood, S. Weston, M. Takigawa et al., Molecular Characterisation of Integrin-Procollagen C-Propeptide Interactions, European Journal of Biochemistry, vol.269, issue.2, pp.274-82, 1997.
DOI : 10.1016/0955-0674(95)80110-3

D. Palmieri, L. Camardella, V. Ulivi, G. Guasco, and P. Manduca, Trimer Carboxyl Propeptide of Collagen I Produced by Mature Osteoblasts Is Chemotactic for Endothelial Cells, Journal of Biological Chemistry, vol.268, issue.1, pp.32658-63, 2000.
DOI : 10.1002/(SICI)1097-0215(19990505)81:3<395::AID-IJC13>3.0.CO;2-V

A. Mahonen, A. Jukkola, L. Risteli, J. Risteli, and P. Maenpaa, Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells, Journal of Cellular Biochemistry, vol.167, issue.2, pp.151-63, 1998.
DOI : 10.1042/bj2860179

H. Hotta, H. Yamada, and H. Takaishi, Type II collagen synthesis in the articular cartilage of a rabbit model of osteoarthritis: expression of type II collagen C-propeptide and mRNA especially during early-stage osteoarthritis, Journal of Orthopaedic Science, vol.10, issue.6, pp.595-607, 2005.
DOI : 10.1007/s00776-005-0947-z

D. Palmieri, S. Poggi, V. Ulivi, G. Casartelli, and P. Manduca, Pro-collagen I COOH-terminal Trimer Induces Directional Migration and Metalloproteinases in Breast Cancer Cells, Journal of Biological Chemistry, vol.60, issue.6, pp.3639-3686, 2003.
DOI : 10.1016/S0092-8674(00)81392-6

T. Lai, Y. Fong, W. Fu, R. Yang, and C. Tang, Stromal cell-derived factor-1 increase ??v??3 integrin expression and invasion in human chondrosarcoma cells, Journal of Cellular Physiology, vol.23, issue.2, pp.334-376, 2009.
DOI : 10.1016/j.orthres.2005.04.004.1100230633

D. Palmieri, S. Astigiano, and O. Barbieri, Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells, Experimental Cell Research, vol.314, issue.11-12, pp.2289-98, 2008.
DOI : 10.1016/j.yexcr.2008.04.016

D. Visigalli, D. Palmieri, and A. Strangio, The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts, BMC Cancer, vol.27, issue.11, p.59, 2009.
DOI : 10.1007/s10555-007-9105-8

O. Reilly, M. Boehm, T. Shing, and Y. , Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth, Cell, vol.88, issue.2, pp.277-85, 1997.
DOI : 10.1016/S0092-8674(00)81848-6

A. Sudhakar, H. Sugimoto, C. Yang, J. Lively, M. Zeisberg et al., Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by ??v??3 and ??5??1 integrins, Proceedings of the National Academy of Sciences, vol.281, issue.6, pp.4766-71, 2003.
DOI : 10.1152/ajplung.2001.281.6.L1500

T. Mundel and R. Kalluri, Type IV collagen-derived angiogenesis inhibitors, Microvascular Research, vol.74, issue.2-3, pp.85-94, 2007.
DOI : 10.1016/j.mvr.2007.05.005

URL : http://europepmc.org/articles/pmc3998721?pdf=render

D. Couchourel, I. Aubry, and A. Delalandre, Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production, Arthritis & Rheumatism, vol.52, issue.5, pp.1438-50, 2009.
DOI : 10.4049/jimmunol.169.1.507

H. Brem and J. Folkman, Inhibition of tumor angiogenesis mediated by cartilage, Journal of Experimental Medicine, vol.141, issue.2, pp.427-466, 1975.
DOI : 10.1084/jem.141.2.427

C. Niyibizi, J. Wu, and D. Eyre, The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol.916, issue.3, pp.493-502, 1987.
DOI : 10.1016/0167-4838(87)90196-8

S. Mclaughlin and N. Bulleid, Molecular recognition in procollagen chain assembly, Matrix Biology, vol.16, issue.7, pp.369-77, 1998.
DOI : 10.1016/S0945-053X(98)90010-5

D. Hulmes, Building Collagen Molecules, Fibrils, and Suprafibrillar Structures, Journal of Structural Biology, vol.137, issue.1-2, pp.2-10, 2002.
DOI : 10.1006/jsbi.2002.4450

URL : https://hal.archives-ouvertes.fr/hal-00313823

M. Soderstrom, T. Bohling, T. Ekfors, L. Nelimarkka, H. Aro et al., Molecular profiling of human chondrosarcomas for matrix production and cancer markers, International Journal of Cancer, vol.355, issue.Suppl, pp.144-51, 2002.
DOI : 10.1042/bj3550577

M. Gebauer, J. Saas, and F. Sohler, Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1??, Osteoarthritis and Cartilage, vol.13, issue.8, pp.697-708, 2005.
DOI : 10.1016/j.joca.2005.04.004

T. Kalinski, S. Sel, I. Kouznetsova, M. Ropke, and A. Roessner, Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors, Pathology - Research and Practice, vol.205, issue.5, pp.339-384, 2009.
DOI : 10.1016/j.prp.2008.12.008

J. Burger and T. Kipps, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, vol.107, issue.5, pp.1761-1768, 2006.
DOI : 10.1182/blood-2005-08-3182

J. Uria, M. Balbin, and J. Lopez, Collagenase-3 (MMP-13) Expression in Chondrosarcoma Cells and Its Regulation by Basic Fibroblast Growth Factor, The American Journal of Pathology, vol.153, issue.1, pp.91-101, 1998.
DOI : 10.1016/S0002-9440(10)65549-6

M. Rehn, T. Veikkola, and E. Kukk-valdre, Interaction of endostatin with integrins implicated in angiogenesis, Proceedings of the National Academy of Sciences, vol.252, issue.1, pp.1024-1033, 2001.
DOI : 10.1006/bbrc.1998.9617